Predictors of response in the treatment of moderate depression

AUTOR(ES)

Bastos, Andre G., Guimarães, Luciano S., Trentini, Clarissa M.

FONTE

Rev. Bras. Psiquiatr.

DATA DE PUBLICAÇÃO

24/11/2016

RESUMO

Objective: To identify neurocognitive and sociodemographic variables that could be associated with clinical response to three modalities of treatment for depression, as well as variables that predicted superior response to one treatment over the others. Method: The present study derives from a research project in which depressed patients (n=272) received one of three treatments – long-term psychodynamic psychotherapy (n=90), fluoxetine therapy (n=91), or a combination thereof (n=91) – over a 24-month period. Results: Sociodemographic variables were not found to be predictive. Six predictive neurocognitive variables were identified: three prognostic variables related to working memory and abstract reasoning; one prescriptive variable related to working memory; and two variables found to be moderators. Conclusions: The results of this study indicate subgroups of patients who might benefit from specific therapeutic strategies and subgroups that seem to respond well to long-term psychodynamic psychotherapy and combined therapy. The moderators found suggest that abstract reasoning and processing speed may influence the magnitude and/or direction of clinical improvement.

Documentos Relacionados

• Enhancement of Treatment Response in Depression in the Primary Care Setting
• Response predictors to treatment with pegylated interferon in chronic hepatitis B
• Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks
• Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks
• NICE guidelines for the management of depression: Are clear for severe depression, but uncertain for mild or moderate depression